HAWTHORNE, N.Y., Feb. 11, 2009 (GLOBE NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. (“Taro,” the “Company”) (Pink Sheets:TAROF) reported today that it has received approval from the U.S. Food and Drug Administration (“FDA”) for its Abbreviated New Drug Application (“ANDA”) for Levetiracetam Oral Solution, 100 mg/mL (“levetiracetam oral solution”).
